KIAA1114, a full-length protein encoded by the trophinin gene,is a novel surface marker for isolating tumor-initiating cells of multiple hepatocellular carcinoma subtypes

Oncotarget

Volumn 5, Issue 5, 2014, Pages 1226-1240

  Kim, Sae Won ^a   Yang, Hyun Gul ^a   Kang, Moon Cheol ^a   Lee, Seungwon ^a   Namkoong, Hong ^a   Lee, Seung Woo ^a   Sung, Young Chul ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

Cell surface marker; Hepatocellular carcinoma; Kiaa1114; Monoclonal antibody; Tumor initiating cells

Indexed keywords

ALPHA FETOPROTEIN; CELL ANTIGEN; CELL SURFACE PROTEIN; DNA VACCINE; MONOCLONAL ANTIBODY; PROTEIN KIAA1114; TUMOR MARKER; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; MEMBRANE ANTIGEN; MESSENGER RNA; TRO PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CANCER MODEL; CANCER PATIENT; CANCER PROGNOSIS; CARCINOGENICITY; CARCINOMA CELL; CELL FUNCTION; CELL ISOLATION; CELL MIGRATION; CELL TYPE; CONTROLLED STUDY; DIAGNOSTIC VALUE; GENE EXPRESSION; GENETIC TRAIT; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL CARCINOMA; MARKER GENE; MOUSE; NONHUMAN; PRIMARY TUMOR; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; RNA TRANSLATION; TISSUE SECTION; TROPHININ GENE; TUMOR INITIATING CELL; TUMOR SPHEROID; XENOTRANSPLANTATION; ANIMAL; BAGG ALBINO MOUSE; BILE DUCT CARCINOMA; BILE DUCT TUMOR; CANCER STEM CELL; DRUG SCREENING; GENETICS; IMMUNOLOGY; INTRAHEPATIC BILE DUCT; LIVER; LIVER TUMOR; METABOLISM; MULTICELLULAR SPHEROID; TUMOR CELL LINE;

ALPHA-FETOPROTEINS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, SURFACE; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CHOLANGIOCARCINOMA; HUMANS; LIVER; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; NEOPLASTIC STEM CELLS; RNA, MESSENGER; SPHEROIDS, CELLULAR; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELL ASSAY;

EID: 84898640701     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1677     Document Type: Article

References (44)

1. Valent P, Bonnet D, De Maria R, Lapidot T, Copland M, Melo JV, Chomienne C, Ishikawa F, Schuringa JJ, Stassi G, Huntly B, Herrmann H, Soulier J, Roesch A, Schuurhuis GJ, Wohrer S, et al. Cancer stem cell definitions and terminology: the devil is in the details. Nat Rev Cancer. 2012; 12(11):767-775.
2. Magee JA, Piskounova E and Morrison SJ. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell. 2012; 21(3):283-296.
3. Abdullah LN and Chow EK. Mechanisms of chemoresistance in cancer stem cells. Clinical and translational medicine. 2013; 2(1):3.
4. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J and Weinberg RA. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133(4):704-715.
5. Malanchi I, Santamaria-Martinez A, Susanto E, Peng H, Lehr HA, Delaloye JF and Huelsken J. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature. 2012; 481(7379):85-89.
6. Yamashita T and Wang XW. Cancer stem cells in the development of liver cancer. J Clin Invest. 2013; 123(5):1911-1918.
7. Lee JS and Thorgeirsson SS. Functional and genomic implications of global gene expression profiles in cell lines from human hepatocellular cancer. Hepatology. 2002; 35(5):1134-1143.
8. Yamashita T, Ji J, Budhu A, Forgues M, Yang W, Wang HY, Jia H, Ye Q, Qin LX, Wauthier E, Reid LM, Minato H, Honda M, Kaneko S, Tang ZY and Wang XW. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology. 2009; 136(3):1012-1024.
9. Yamashita T, Honda M, Nakamoto Y, Baba M, Nio K, Hara Y, Zeng SS, Hayashi T, Kondo M, Takatori H, Yamashita T, Mizukoshi E, Ikeda H, Zen Y, Takamura H, Wang XW, et al. Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma. Hepatology. 2013; 57(4):1484-1497.
10. Nadano D, Sugihara K, Paria BC, Saburi S, Copeland NG, Gilbert DJ, Jenkins NA, Nakayama J and Fukuda MN. Significant differences between mouse and human trophinins are revealed by their expression patterns and targeted disruption of mouse trophinin gene. Biol Reprod. 2002; 66(2):313-321.
11. Aoyama J, Akazawa Y, Kasahara K, Higashiyama Y, Kikuchi I, Fukumoto Y, Saburi S, Nakayama Y, Fukuda MN and Yamaguchi N. Nuclear localization of magphinins, alternative splicing products of the human trophinin gene. J Cell Biochem. 2008; 103(3):765-777.
12. Fukuda MN, Sugihara K and Nakayama J. Trophinin: what embryo implantation teaches us about human cancer. Cancer Biol Ther. 2008; 7(8):1165.
13. Kikuno R, Nagase T, Ishikawa K, Hirosawa M, Miyajima N, Tanaka A, Kotani H, Nomura N and Ohara O. Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res. 1999; 6(3):197-205.
14. Saburi S, Nadano D, Akama TO, Hirama K, Yamanouchi K, Naito K, Tojo H, Tachi C and Fukuda MN. The trophinin gene encodes a novel group of MAGE proteins, magphinins, and regulates cell proliferation during gametogenesis in the mouse. The Journal of biological chemistry. 2001; 276(52):49378-49389.
15. Hofmann K and Stoffel W. PROFILEGRAPH: an interactive graphical tool for protein sequence analysis. Comput Appl Biosci. 1992; 8(4):331-337.
16. Chomez P, De Backer O, Bertrand M, De Plaen E, Boon T and Lucas S. An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res. 2001; 61(14):5544-5551.
17. Fukuda MN, Sato T, Nakayama J, Klier G, Mikami M, Aoki D and Nozawa S. Trophinin and tastin, a novel cell adhesion molecule complex with potential involvement in embryo implantation. Genes Dev. 1995; 9(10):1199-1210.
18. Fukuda MN and Sugihara K. Trophinin in cell adhesion and signal transduction. Front Biosci (Elite Ed). 2012; 4:342-350.
19. Boyle JS, Silva A, Brady JL and Lew AM. DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1997; 94(26):14626-14631.
20. Bates MK, Zhang G, Sebestyen MG, Neal ZC, Wolff JA and Herweijer H. Genetic immunization for antibody generation in research animals by intravenous delivery of plasmid DNA. Biotechniques. 2006; 40(2):199-208.
21. Park SK, Yoon J, Wang L, Shibata TK, Motamedchaboki K, Shim KJ, Chang MS, Lee SH, Tamura N, Hatakeyama S, Nadano D, Sugihara K and Fukuda MN. Enhancement of mouse sperm motility by trophinin-binding peptide. Reprod Biol Endocrinol. 2012; 10:101.
22. Hatakeyama S, Ohyama C, Minagawa S, Inoue T, Kakinuma H, Kyan A, Arai Y, Suga T, Nakayama J, Kato T, Habuchi T and Fukuda MN. Functional correlation of trophinin expression with the malignancy of testicular germ cell tumor. Cancer Res. 2004; 64(12):4257-4262.
23. Yoon H, Min JK, Lee JW, Kim DG and Hong HJ. Acquisition of chemoresistance in intrahepatic cholangiocarcinoma cells by activation of AKT and extracellular signalregulated kinase (ERK)1/2. Biochemical and biophysical research communications. 2011; 405(3):333-337.
24. Seol MA, Chu IS, Lee MJ, Yu GR, Cui XD, Cho BH, Ahn EK, Leem SH, Kim IH and Kim DG. Genome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma. BMC Cancer. 2011; 11:78.
25. Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, Chu PW, Lam CT, Poon RT and Fan ST. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell. 2008; 13(2):153-166.
26. Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, Zheng BJ and Guan XY. Identification and characterizationof tumorigenic liver cancer stem/progenitor cells. Gastroenterology. 2007; 132(7):2542-2556.
27. Lee TK, Castilho A, Cheung VC, Tang KH, Ma S and Ng IO. CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. Cell stem cell. 2011; 9(1):50-63.
28. Haraguchi N, Ishii H, Mimori K, Tanaka F, Ohkuma M, Kim HM, Akita H, Takiuchi D, Hatano H, Nagano H, Barnard GF, Doki Y and Mori M. CD13 is a therapeutic target in human liver cancer stem cells. J Clin Invest. 2010; 120(9):3326-3339.
29. Sakaguchi T, Nishimoto M, Miyagi S, Iwama A, Morita Y, Iwamori N, Nakauchi H, Kiyonari H, Muramatsu M and Okuda A. Putative "stemness" gene jam-B is not required for maintenance of stem cell state in embryonic, neural, or hematopoietic stem cells. Mol Cell Biol. 2006; 26(17):6557-6570.
30. Hui C, Safwani W, Chin S, Malek A, Hassan N, Fazil M, Rooshdi R, Hamid A and Sathappan S. Human serum promotes the proliferation but not the stemness genes expression of human adipose-derived stem cells. Biotechnol Bioproc E. 2012; 17(6):1306-1313.
31. Medici D and Nawshad A. Type I collagen promotes epithelial-mesenchymal transition through ILK-dependent activation of NF-kappaB and LEF-1. Matrix Biol. 2010; 29(3):161-165.
32. Cao L, Zhou Y, Zhai B, Liao J, Xu W, Zhang R, Li J, Zhang Y, Chen L, Qian H, Wu M and Yin Z. Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines. BMC Gastroenterol. 2011; 11:71.
33. Chen Y, Yu D, Zhang H, He H, Zhang C, Zhao W and Shao RG. CD133(+)EpCAM(+) phenotype possesses more characteristics of tumor initiating cells in hepatocellular carcinoma Huh7 cells. Int J Biol Sci. 2012; 8(7):992-1004.
34. Medema JP. Cancer stem cells: the challenges ahead. Nat Cell Biol. 2013; 15(4):338-344.
35. Yamashita T, Forgues M, Wang W, Kim JW, Ye Q, Jia H, Budhu A, Zanetti KA, Chen Y, Qin LX, Tang ZY and Wang XW. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res. 2008; 68(5):1451-1461.
36. Simpson AJ, Caballero OL, Jungbluth A, Chen YT and Old LJ. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer. 2005; 5(8):615-625.
37. Cronwright G, Le Blanc K, Gotherstrom C, Darcy P, Ehnman M and Brodin B. Cancer/testis antigen expression in human mesenchymal stem cells: down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression. Cancer Res. 2005; 65(6):2207-2215.
38. Lifantseva N, Koltsova A, Krylova T, Yakovleva T, Poljanskaya G and Gordeeva O. Expression patterns of cancer-testis antigens in human embryonic stem cells and their cell derivatives indicate lineage tracks. Stem cells international. 2011; 2011:795239.
39. Jaatinen T, Hemmoranta H, Hautaniemi S, Niemi J, Nicorici D, Laine J, Yli-Harja O and Partanen J. Global gene expression profile of human cord blood-derived CD133+ cells. Stem Cells. 2006; 24(3):631-641.
40. Yawata T, Nakai E, Park KC, Chihara T, Kumazawa A, Toyonaga S, Masahira T, Nakabayashi H, Kaji T and Shimizu K. Enhanced expression of cancer testis antigen genes in glioma stem cells. Mol Carcinog. 2010; 49(6): 532-544.
41. Gu W, Yeo E, McMillan N and Yu C. Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal ability. Cancer Gene Ther. 2011; 18(12):897-905.
42. Kim SW, Kim SJ, Park SH, Yang HG, Kang MC, Choi YW, Kim SM, Jeun SS and Sung YC. Complete regression of metastatic renal cell carcinoma by multiple injections of engineered mesenchymal stem cells expressing dodecameric TRAIL and HSV-TK. Clin Cancer Res. 2013; 19(2):415-427.
43. Meng Z, Qin G, Zhang B and Bai J. DNA damaging effects of sulfur dioxide derivatives in cells from various organs of mice. Mutagenesis. 2004; 19(6):465-468.
44. Kim J, Jung J, Lee SJ, Lee JS and Park MJ. Cancer stemlike cells persist in established cell lines through autocrine activation of EGFR signaling. Oncol Lett. 2012; 3(3): 607-612.